Significant Ownership of Neil Kumar

Location
Palo Alto, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Neil Kumar.

Notify me when Neil Kumar files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Neil Kumar

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BBIO BridgeBio Pharma, Inc. Common Stock, par value $0.001 per share 5.4% $376,382,964 10,466,712 NEIL KUMAR 31 Dec 2024

Schedules 13D/G Reported by Neil Kumar:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.